Pharmaceuticals Market Reports

Global Xerostomia Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Product (Salivary Stimulants, Salivary Substitutes, and Dentifrices), By Type (OTC and Prescription), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Xerostomia is characterized as dry mouth caused by decreased or absent saliva flow. Xerostomia is a symptom of toxicity caused by chemotherapy, head, neck radiotherapy, drug side effects, autoimmune illness, or other diseases such as untreated asthma, viruses, and hormonal shifts. Read More »
May 18 : 2021

Global Liver Cancer Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Therapeutic Class (Targeted Therapy and Immunotherapy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Liver cancer is a persistent, life-threatening, and progressing disease that progresses in liver cells. The liver is one of the main functional organs in the body found on the upper right side of the abdomen under the right lung. Read More »
May 18 : 2021

Global Head and Neck Cancer Therapeutics Market Size, Trends, and Analysis - Forecasts To 2026 By Therapeutic Class (PD Inhibitors, EGFR Inhibitors, and Microtubule Inhibitors), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The growth of the head & neck cancer therapeutics market is driven due to the advancement of new & cost-effective therapies, various side effects associated with radiation therapy & chemotherapy, growing healthcare expenditure, and improved government policies are estimated to propel the market forward throughout the forecast period. There are a lot of medications for treating head & neck cancer, that could be used alone or in conjunction. Read More »
May 18 : 2021

Global Tuberculosis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Disease Type (Active TB and Latent TB), By Therapy (First-Line and Second-Line), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Tuberculosis is triggered by a bacterium named Mycobacterium tuberculosis whose primary area of infection is the lungs but may often damage other organs of the body. The basic way of transmission of Tuberculosis is via the air; when a person infected with Tuberculosis comes into contact with another person, this leads to the transmission of the infection by talking, coughing, or sneezing. Read More »
May 18 : 2021